Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 2/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | GPBAR1 | Q8TDU6 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | HTR2B | P41595 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.38 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2456698 | 1.00 | MCHR1 (0.41) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL6283599 | 1.00 | MCHR1 (0.41) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL1396371 | 0.98 | LTA4H (0.41) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL2256189 | 0.93 | L3MBTL1 (0.41) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL1389283 | 0.88 | TLR8 (0.37) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL6538544 | 0.86 | GPBAR1 (0.42) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL20694959 | 0.84 | GPBAR1 (0.43) | MCHR1TLR8LTA4HGPBAR1TSHR | |
| SCHEMBL6538521 | 0.84 | KCNA3 (0.52) | LTA4HALDH1A1HDAC6CYSLTR2CYSLTR1 | |
| SCHEMBL64412 | 0.81 | ALDH1A1 (0.34) | TLR8LTA4HALDH1A1MAPTGAA | |
| SCHEMBL2456166 | 0.81 | NCF1 (0.41) | TSHRLMNAALDH1A1MEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| EP-3904337-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM Wako Pure Chemical Corporation (JP) | 2021-11-03 | — | — | EP | disclosed |
| EP-3439097-B1 | ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-10727534-B2 | Electrolyte solution containing magnesium ions | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| WO-2020138377-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | 富士フイルム和光純薬株式会社 | 2020-07-02 | — | — | WO | disclosed |
| US-20190131657-A1 | ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-05-02 | — | — | US | disclosed |
| EP-3439097-A1 | ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM Wako Pure Chemical Corporation (JP) | 2019-02-06 | — | — | EP | disclosed |
| US-8012362-B2 | Electromagnetic shielding light-transmitting member and method for manufacturing same | TOPPAN PRINTING CO., LTD. (JP) | 2011-09-06 | — | — | US | disclosed |
| US-20090206754-A1 | Electromagnetic shielding light-transmitting member and method for manufacturing same | TOPPAN PRINTING CO., LTD. (JP) | 2009-08-20 | — | — | US | disclosed |
| US-20060121392-A1 | Optical filter and display using the same | DAI NIPPON PRINTING CO., LTD. (JP) | 2006-06-08 | — | — | US | disclosed |
| US-6743776-B2 | ANTIFUNGAL, BETA-1,3-GLUCAN SYNTHASE INHIBITOR, PNEUMOCYSTIS CARINII; AMIDATION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-01 | — | — | US | disclosed |
| US-20020193560-A1 | CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY | ASTELLAS PHARMA INC. (JP) | 2002-12-19 | — | — | US | disclosed |
| EP-0782164-B1 | Plasma display filter | MITSUI CHEMICALS INC (JP) | 2002-04-10 | — | — | EP | disclosed |
| EP-0941236-A1 | CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-15 | — | — | EP | disclosed |
| US-5804102-A | USE OF METAL COMPLEXES TO CUT OFF NEAR INFRARED RAYS; PREVENTION OF INTERFERENCE BETWEEN TELEVISION AND OTHER REMOTE CONTROLLED ELECTRONICS | MITSUI CHEMICALS, INC. (JP) | 1998-09-08 | — | — | US | disclosed |
| WO-1998023637-A1 | CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-04 | — | — | WO | disclosed |
| EP-0782164-A1 | Plasma display filter | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-07-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10727534-B2 | Electrolyte solution containing magnesium ions | MLX, PRDX1, PRDX6 | MCHR1 2534/4885TLR8 2468/4885LTA4H 2785/4885 |
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | SLC26A3, PRDX4, PRDX2 | MCHR1 1586/4885TLR8 4273/4885LTA4H 1605/4885 |
| US-20190131657-A1 | ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS | MLX, PRDX1, PRDX6 | MCHR1 2534/4885TLR8 2468/4885LTA4H 2785/4885 |
| US-20020193560-A1 | CYCLOHEXAPEPTIDES HAVING ANTIMICROBIAL ACTIVITY | NGLY1, CHIT1, MANBA | MCHR1 485/4885TLR8 2738/4885LTA4H 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.